Created at Source Raw Value Validated value
Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: adult patients (age ≥ 18 years); covid-19 diagnosis confirmed by: detection of sars-cov-2 by reverse transcription polymerase chain reaction (rt-pcr), or rapid genetic or antigen tests validated by brazilian national health surveillance agency (anvisa); mild or moderate symptoms without indication for hospitalization; symptoms started seven days ago or less; be able to access the study's online questionnaire.

inclusion criteria: adult patients (age ≥ 18 years); covid-19 diagnosis confirmed by: detection of sars-cov-2 by reverse transcription polymerase chain reaction (rt-pcr), or rapid genetic or antigen tests validated by brazilian national health surveillance agency (anvisa); mild or moderate symptoms without indication for hospitalization; symptoms started seven days ago or less; be able to access the study's online questionnaire.

Aug. 25, 2021, 7:30 p.m. usa

inclusion criteria: 1. adult patients (age ≥ 18 years); 2. covid-19 diagnosis confirmed by: 1. detection of sars-cov-2 by reverse transcription polymerase chain reaction (rt-pcr), or 2. rapid genetic or antigen tests validated by brazilian national health surveillance agency (anvisa); 3. mild or moderate symptoms without indication for hospitalization; 4. symptoms started seven days ago or less; 5. be able to access the study's online questionnaire.

inclusion criteria: 1. adult patients (age ≥ 18 years); 2. covid-19 diagnosis confirmed by: 1. detection of sars-cov-2 by reverse transcription polymerase chain reaction (rt-pcr), or 2. rapid genetic or antigen tests validated by brazilian national health surveillance agency (anvisa); 3. mild or moderate symptoms without indication for hospitalization; 4. symptoms started seven days ago or less; 5. be able to access the study's online questionnaire.

Aug. 17, 2021, 6 p.m. usa

inclusion criteria: 1. adult patients (age ≥ 18 years); 2. covid-19 diagnosis confirmed by: 1. detection of sars-cov-2 by rt-pcr, or 2. rapid genetic or antigen tests validated by anvisa; 3. mild or moderate symptoms without indication for hospitalization; 4. symptoms started seven days ago or less; 5. be able to access the study's online questionnaire.

inclusion criteria: 1. adult patients (age ≥ 18 years); 2. covid-19 diagnosis confirmed by: 1. detection of sars-cov-2 by rt-pcr, or 2. rapid genetic or antigen tests validated by anvisa; 3. mild or moderate symptoms without indication for hospitalization; 4. symptoms started seven days ago or less; 5. be able to access the study's online questionnaire.